T 2719/19 (Allograft survival/ALEXION) of 20.11.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T271919.20231120
- Date of decision
- 20 November 2023
- Case number
- T 2719/19
- Petition for review of
- -
- Application number
- 16160321.2
- IPC class
- C07K 16/18A61K 39/395
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- T 2719/19 Prolongation de la survie d'une allogreffe/ALEXION 2022-01-28T 2719/19 Verlängerung der Lebensdauer eines Allotransplantats/ALEXION 2022-01-28T 2719/19 Prolongation of survival of an allograft/ALEXION 2022-01-28
- Abstracts for this decision
- Abstract on EPC2000 Art 087(1)
- Application title
- Prolongation of survival of an allograft by inhibiting complement activity
- Applicant name
- Alexion Pharmaceuticals, Inc.
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 87(1)
- Keywords
- Priority - (yes)
Novelty - (yes) - Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside
2. The case is remitted to the examining division with the order to grant a patent based on the set of claims filed 8 November 2016, with the description and drawings to be adapted thereto, as necessary.